Patrick Donnelly
Stock Analyst at Citigroup
(3.57)
# 873
Out of 4,996 analysts
339
Total ratings
50.27%
Success rate
5.37%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Maintains: Buy | $1,400 → $1,600 | $1,204.43 | +32.84% | 14 | Aug 21, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Neutral | $225 → $200 | $163.79 | +22.11% | 10 | Aug 21, 2025 | |
| TECH Bio-Techne | Upgrades: Buy | $55 → $70 | $51.84 | +35.03% | 12 | Aug 21, 2025 | |
| CAI Caris Life Sciences | Maintains: Buy | $34 → $42 | $29.19 | +43.88% | 2 | Aug 13, 2025 | |
| QDEL QuidelOrtho | Maintains: Buy | $50 → $40 | $28.33 | +41.19% | 5 | Aug 6, 2025 | |
| BRKR Bruker | Maintains: Neutral | $40 → $38 | $31.04 | +22.42% | 17 | Aug 4, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $150 → $200 | $148.56 | +34.63% | 21 | Jul 9, 2025 | |
| HOLX Hologic | Upgrades: Buy | $60 → $80 | $67.21 | +19.03% | 15 | Jul 9, 2025 | |
| ILMN Illumina | Downgrades: Sell | $85 → $80 | $91.69 | -12.75% | 17 | Jul 9, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $400 → $350 | $271.36 | +28.98% | 15 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $350 | $269.90 | +29.68% | 15 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $11.72 | +27.99% | 12 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $22 → $18 | $11.84 | +52.03% | 8 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $210 | $179.56 | +16.95% | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $650 → $570 | $464.24 | +22.78% | 19 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $185 | $188.99 | -2.11% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $184.84 | +43.37% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $8.68 | +164.98% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $20 | $15.82 | +26.42% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $53.57 | +40.00% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $123.39 | +33.72% | 26 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $45 | $60.03 | -25.04% | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $25.66 | +9.12% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $84.06 | +72.50% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $62 | $43.90 | +40.77% | 13 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $291.71 | +2.84% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $3.20 | +181.25% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $3.09 | -11.00% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $280.61 | -7.34% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $6.04 | -0.66% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $7.70 | +315.58% | 2 | Nov 30, 2018 |
Mettler-Toledo International
Aug 21, 2025
Maintains: Buy
Price Target: $1,400 → $1,600
Current: $1,204.43
Upside: +32.84%
ICON Public Limited Company
Aug 21, 2025
Downgrades: Neutral
Price Target: $225 → $200
Current: $163.79
Upside: +22.11%
Bio-Techne
Aug 21, 2025
Upgrades: Buy
Price Target: $55 → $70
Current: $51.84
Upside: +35.03%
Caris Life Sciences
Aug 13, 2025
Maintains: Buy
Price Target: $34 → $42
Current: $29.19
Upside: +43.88%
QuidelOrtho
Aug 6, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $28.33
Upside: +41.19%
Bruker
Aug 4, 2025
Maintains: Neutral
Price Target: $40 → $38
Current: $31.04
Upside: +22.42%
Charles River Laboratories International
Jul 9, 2025
Upgrades: Buy
Price Target: $150 → $200
Current: $148.56
Upside: +34.63%
Hologic
Jul 9, 2025
Upgrades: Buy
Price Target: $60 → $80
Current: $67.21
Upside: +19.03%
Illumina
Jul 9, 2025
Downgrades: Sell
Price Target: $85 → $80
Current: $91.69
Upside: -12.75%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $271.36
Upside: +28.98%
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $269.90
Upside: +29.68%
Mar 4, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $11.72
Upside: +27.99%
Mar 4, 2025
Maintains: Neutral
Price Target: $22 → $18
Current: $11.84
Upside: +52.03%
Mar 4, 2025
Maintains: Neutral
Price Target: $225 → $210
Current: $179.56
Upside: +16.95%
Mar 4, 2025
Maintains: Neutral
Price Target: $650 → $570
Current: $464.24
Upside: +22.78%
Mar 4, 2025
Downgrades: Neutral
Price Target: $185
Current: $188.99
Upside: -2.11%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $184.84
Upside: +43.37%
Dec 11, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $8.68
Upside: +164.98%
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $15.82
Upside: +26.42%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $53.57
Upside: +40.00%
Aug 22, 2024
Maintains: Buy
Price Target: $150 → $165
Current: $123.39
Upside: +33.72%
Aug 8, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $60.03
Upside: -25.04%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $25.66
Upside: +9.12%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $84.06
Upside: +72.50%
Feb 8, 2024
Maintains: Buy
Price Target: $64 → $62
Current: $43.90
Upside: +40.77%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $291.71
Upside: +2.84%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $3.20
Upside: +181.25%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $3.09
Upside: -11.00%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $280.61
Upside: -7.34%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $6.04
Upside: -0.66%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $7.70
Upside: +315.58%